NCT05501236

Brief Summary

Polysomnography (PSG) and drug-induced sleep endoscopy (DISE) are widely used diagnostic studies for assessing obstructive sleep apnea (OSA) severity and collapse patterns of the upper airway anatomy during sleep. Hypoglossal nerve stimulation (HNS) therapy for obstructive sleep apnea suffers from variable response at the level of the soft palate. The Investigators propose a study examining the physiologic effect of ansa cervicalis stimulation (ACS) alone and in combination with HNS during PSG and DISE.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
7mo left

Started Nov 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Nov 2022Nov 2026

First Submitted

Initial submission to the registry

July 28, 2022

Completed
18 days until next milestone

First Posted

Study publicly available on registry

August 15, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

November 3, 2022

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Last Updated

October 15, 2025

Status Verified

October 1, 2025

Enrollment Period

3.6 years

First QC Date

July 28, 2022

Last Update Submit

October 12, 2025

Conditions

Outcome Measures

Primary Outcomes (11)

  • Basic physiologic measurements during Drug Induced Sleep Endoscopy (DISE) - Airway cross sectional diameter

    Airway cross-sectional diameter (mm\^2) will be measured throughout the operative procedure via flexible fiberoptic nasopharyngoscopy.

    During DISE, approximately 15 minutes

  • Basic physiologic measurements during Drug Induced Sleep Endoscopy (DISE) - Airflow data

    Airflow data (L/min) will be measured throughout the operative procedure via a pneumotachometer applied to the nose.

    During DISE, approximately 15 minutes

  • Basic physiologic measurements during Drug Induced Sleep Endoscopy (DISE) - Upper airway pressure changes

    Upper airway pressure changes (cmH20) will be measured throughout the operative procedure via a pneumotachometer applied to the nose.

    During DISE, approximately 15 minutes

  • Basic physiologic measurements during Drug Induced Sleep Endoscopy (DISE) - Respiratory effort data

    Respiratory effort data (mV) will be measured throughout the operative procedure via two respiratory inductance plethysmography belts.

    During DISE, approximately 15 minutes

  • Basic physiologic measurements during Polysomnography (PSG) - Airflow data

    Airflow data (L/min) will be measured during the sleep study via a pneumotachometer applied to the nose.

    During sleep study exam (PSG), approximately 8 hours

  • Basic physiologic measurements during Polysomnography (PSG) - Electroencephalogram (EEG)

    EEG (mV) will be collected during the sleep study via skin surface electrodes.

    During sleep study exam (PSG), approximately 8 hours

  • Basic physiologic measurements during Polysomnography (PSG) - Electrocardiogram (EKG)

    EKG (mV) will be collected during the sleep study via skin surface electrodes.

    During sleep study exam (PSG), approximately 8 hours

  • Basic physiologic measurements during Polysomnography (PSG) - Electroocoulogram (EOG)

    EOG (mV) will be collected during the sleep study via skin surface electrodes.

    During sleep study exam (PSG), approximately 8 hours

  • Basic physiologic measurements during Polysomnography (PSG) - Electromyography (EMG)

    EMG data (mV) will be collected during the sleep study via skin surface electrodes.

    During sleep study exam (PSG), approximately 8 hours

  • Basic physiologic measurements during Polysomnography (PSG) - Respiratory effort data

    Respiratory effort data (mV) will be collected during the sleep study via respiratory inductance plethysmography.

    During sleep study exam (PSG), approximately 8 hours

  • Basic physiologic measurements during Polysomnography (PSG) - Video data

    Video data will be collected during the sleep study via in-room camera.

    During sleep study exam (PSG), approximately 8 hours

Secondary Outcomes (1)

  • Amount of current needed for adequate stimulation

    Collected during operative and sleep study procedures, taking about 15 minutes.

Study Arms (1)

Muscle stimulation

EXPERIMENTAL

Consented participants who meet eligibility will have a drug induced sleep endoscopy (DISE) and second sleep study and the Grass S88 (or comparable) muscle stimulator.

Device: Grass S88 Muscle Stimulator

Interventions

The Grass S88 nerve and muscle stimulator is a widely-used tool in electromyography and nerve conduction studies. During the DISE and second sleep study, fine-wire electrodes will be placed into the hypoglossal nerve or genioglossus muscle. Two more electrodes are placed transcutaneously, proximate to the bilateral branches of the cervicalis innervating the sternothyroid muscle in the anterior neck.

Muscle stimulation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Consenting adults with BMI≥ 25 and ≤ 40 kg/m2
  • Obstructive sleep apnea with an AHI between 20 and 80 events/hr (with hypopneas defined by 4% oxyhemoglobin desaturations); ≥80% obstructive events.

You may not qualify if:

  • Chronic use of opiate medications, illicit drug use, or alcohol dependency
  • Other known concomitant sleep disorder (e.g., central sleep apnea, periodic limb movements, narcolepsy)
  • Clinical history or evidence of cardiopulmonary disease (or oxygen use), liver, renal, immunodeficiency, neurodegenerative diseases, or previous adverse reactions to anesthesia.
  • Prior upper airway reconstructive surgery excluding tonsillectomy (e.g., cleft palate repair, uvulopalatopharyngoplasty)
  • Indwelling neurostimulation device (e.g. cardiac pacemaker, spinal, vagal, or hypoglossal nerve stimulator)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vanderbilt University Medical Center

Nashville, Tennessee, 37232, United States

RECRUITING

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • David T. Kent, MD

    Vanderbilt University Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Katie Hartley-Estes, RPSGT

CONTACT

Nicole L Jones, MS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: All patients who meet eligibility will undergo the screening sleep study, muscle stimulation during operative DISE procedure, and muscle stimulation during second sleep study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, Department of Otolaryngology-Head and Neck Surgery

Study Record Dates

First Submitted

July 28, 2022

First Posted

August 15, 2022

Study Start

November 3, 2022

Primary Completion (Estimated)

May 30, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

October 15, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

We do not plan to share IPD with other researchers.

Locations